US Stock MarketDetailed Quotes

Bright Minds Biosciences (DRUG)

Watchlist
  • 72.000
  • -0.250-0.35%
Close Mar 13 16:00 ET
  • 72.000
  • 0.0000.00%
Post 20:01 ET
704.68MMarket Cap-35.59P/E (TTM)

Bright Minds Biosciences (DRUG) Key Financial Indicators

DRUG Earnings per Share (EPS)

According to the latest financial report of Bright Minds Biosciences, the latest earnings per share (TTM) for the company is -0.97. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CAD

Quarterly

Loading...

DRUG Free Cash Flow (FCF)

Interested in knowing about Bright Minds Biosciences's free cash flow? The latest report shows it as -5.82M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: CAD

Quarterly

Loading...

DRUG Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Bright Minds Biosciences shows that the company's current ratio is 57.37, indicating healthy liquidity.

Currency: CAD

Quarterly

Loading...

DRUG Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Bright Minds Biosciences, the quick ratio is 56.59, indicating that the company can meet its short-term debt obligations.

Currency: CAD

Quarterly

Loading...

DRUG Return on Equity (ROE)

Want to learn more about the financial health of Bright Minds Biosciences? The latest ROE figure is -8.83%, indicating that the company has stable profitability.

Currency: CAD

Quarterly

Loading...

DRUG Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Bright Minds Biosciences, the total asset return on investment (ROA) is -8.63%.

Currency: CAD

Quarterly

Loading...

DRUG Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Bright Minds Biosciences's latest financial report to see how their gross margin is doing - currently at --.

Currency: CAD

Quarterly

Loading...

DRUG Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Bright Minds Biosciences, the net profit margin is --, which is a good sign for its profitability.

Currency: CAD

Quarterly

Loading...

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More